Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 422 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Genetic Risk and Cancer Estimation Study

    Rochester, MN, La Crosse, WI

  2. CAncer Survivor CArdiomyopathy DEtection (CASCADE) Pilot Study

    Rochester, MN

  3. Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

    Rochester, MN

  4. Patient Adherence and Symptoms During Post-operative Fluid Restriction Protocol After Transsphenoidal Surgery

    Jacksonville, FL

  5. A Study to Assess Endometrial Cancer Recurrence in Patients After 36 Months

    Rochester, MN

  6. Effectiveness of Nurse-based Care Coordination on Readmissions among Primary Care Patients: a Stepped Wedge Cluster Randomized Trial

    Rochester, MN

  7. Image-based Mapping of Brain Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  9. A Study to Evaluate Thymoma Recurrence

    Rochester, MN

  10. A Study to Develop and Maintain a Registry of Specimens from Patients with Bladder Cancer

    Jacksonville, FL

.

Mayo Clinic Footer